Beta 1 Selective Beta Blockers and Cognitive Functions in Patients With Coronary Artery Disease: A Cross Sectional Study.
The association between current beta 1 selective beta blocker use and cognitive function was evaluated in 722 patients with coronary artery disease without dementia. Beta 1 selective beta blocker use was associated with worse incidental learning independently of sociodemographic characteristics, clinical coronary artery disease severity, and depression/anxiety.
The Journal of neuropsychiatry and clinical neurosciences